Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Obesity Due to Melanocortin 4 Receptor Deficiency”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Study completedNCT03287960
What this trial is testing

Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity

Who this might be right for
Leptin Receptor Deficiency Obesity
Rhythm Pharmaceuticals, Inc. 15
Large-scale testing (Phase 3)Study completedNCT02896192
What this trial is testing

Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity

Who this might be right for
Pro-opiomelanocortin (POMC) Deficiency Obesity
Rhythm Pharmaceuticals, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT03013543
What this trial is testing

Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

Who this might be right for
Genetic ObesityObesityObesity Due to Melanocortin 4 Receptor Deficiency
Rhythm Pharmaceuticals, Inc. 213

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation